Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBIT Growth (5y) (2014 - 2026)

Analysis

Astrazeneca (AZN) EBIT Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn
5 Bhp 220.99 Bn 202.45 Bn -
6 Rio Tinto 206.31 Bn 201.93 Bn -
7 Diageo 192.64 Bn 190.61 Bn -
8 National Grid 165.59 Bn 161.82 Bn -
9 Unilever 135.28 Bn 128.25 Bn -
10 Hdfc Bank 119.43 Bn 82.28 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.93%
Mar 31, 2026 17.51%
Dec 31, 2025 14.90%
Sep 30, 2025 25.07%
Jun 30, 2025 22.26%
Mar 31, 2025 24.67%
Dec 31, 2024 5.07%
Sep 30, 2024 22.71%
Jun 30, 2024 40.98%
Mar 31, 2024 23.21%
Dec 31, 2023 45.23%
Sep 30, 2023 18.09%
Jun 30, 2023 26.34%
Mar 31, 2023 29.64%
Dec 31, 2022 31.16%
Sep 30, 2022 1.62%
Jun 30, 2022 -10.24%
Mar 31, 2022 -0.87%
Dec 31, 2021 -17.27%
Sep 30, 2021 -29.40%